Japan, Oct. 7 -- ANAVEX LIFE SCIENCES CORP has got intellectual property rights for 'ENANTIOMERS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE (ANAVEX2-73) AND USE THEREOF IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS MODULATED BY THE SIGMA 1 RECEPTOR.' Other related details are as follows:

Application Number: JP,2025-008427

Category (FI): A61K31/341,C12Q1/02,A61P25/28

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Jan. 21, 2025

Publication Date: April 10, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....